Vmn2r79 Inhibitors
Vmn2r79 can function through various mechanisms to disrupt the activity of this protein. Bicuculline, for instance, is a competitive antagonist of GABA-A receptors, which are part of the olfactory system's neuromodulatory network. By inhibiting these receptors, bicuculline alters the processing of olfactory signals, potentially leading to a reduction in Vmn2r79 activity due to changes in the olfactory signal processing landscape. Similarly, Olfactory Receptor Antagonist 1 binds to specific olfactory receptors, inhibiting the signaling cascade that Vmn2r79 is involved in, thereby reducing its activity. Copper sulfate, with its ability to bind and interfere with the function of various olfactory receptors, can inhibit the downstream signaling pathways that include Vmn2r79. Thioridazine, by blocking receptors involved in olfactory signaling, may also extend its inhibitory effects to pathways involving Vmn2r79.
Methyllycaconitine citrate and hexamethonium both target nicotinic acetylcholine receptors, which are expressed in the olfactory bulb, and their blockade could disrupt the signal transduction pathways that Vmn2r79 participates in. Tetracaine and lidocaine, as sodium channel blockers, can inhibit neuronal excitability, which is crucial for the proper functioning of olfactory neurons expressing Vmn2r79. Ruthenium Red, by blocking calcium channels, can also influence the olfactory signal transduction in a way that leads to the inhibition of Vmn2r79. Chloroquine, through its known action of blocking certain olfactory receptors, can inhibit the signaling cascade involving Vmn2r79. Mecamylamine's non-selective antagonism of nicotinic acetylcholine receptors can indirectly inhibit Vmn2r79 by affecting the cholinergic receptors in the olfactory receptor neurons. Lastly, dihydro-β-erythroidine's antagonism of the nicotinic acetylcholine receptor can decrease the excitability of the neurons in which Vmn2r79 is expressed, resulting in a reduction of its functional activity. Each chemical, by targeting specific pathways or receptors, contributes to the collective inhibition of the Vmn2r79 protein, thereby decreasing its functional output in the olfactory system.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(+)-Bicuculline | 485-49-4 | sc-202498 sc-202498A | 50 mg 250 mg | $82.00 $281.00 | ||
Bicuculline is a competitive antagonist of GABA-A receptors, which are indirectly related to the olfactory system where Vmn2r79 operates. Inhibition of GABA-A receptors can alter the processing of olfactory signals and potentially reduce the activity of Vmn2r79 by altering the general olfactory processing environment. | ||||||
P22077 | 1247819-59-5 | sc-478536 | 10 mg | $165.00 | ||
This compound is known to bind and inhibit specific olfactory receptors, which may lead to a reduction in the signaling cascade that Vmn2r79 is involved in, thereby decreasing its functional activity. | ||||||
Copper(II) sulfate | 7758-98-7 | sc-211133 sc-211133A sc-211133B | 100 g 500 g 1 kg | $46.00 $122.00 $189.00 | 3 | |
Copper ions can bind to and interfere with the function of several olfactory receptors. By binding to these receptors, copper sulfate might inhibit the downstream signaling pathways that Vmn2r79 is a part of, leading to its functional inhibition. | ||||||
Thioridazine | 50-52-2 | sc-473180 | 50 mg | $500.00 | ||
Thioridazine is an antipsychotic known to block several types of receptors, including some that are involved in olfactory signaling. Its broad receptor blockade could extend to pathways involving Vmn2r79, hence functionally inhibiting its activity. | ||||||
Methyllycaconitine citrate | 112825-05-5 | sc-253043 sc-253043A | 5 mg 25 mg | $119.00 $406.00 | 2 | |
Methyllycaconitine is an antagonist of alpha-7 nicotinic acetylcholine receptors, which are expressed in the olfactory bulb. Blocking these receptors could disrupt olfactory signal transduction pathways that include Vmn2r79. | ||||||
Tetracaine | 94-24-6 | sc-255645 sc-255645A sc-255645B sc-255645C sc-255645D sc-255645E | 5 g 25 g 100 g 500 g 1 kg 5 kg | $66.00 $309.00 $500.00 $1000.00 $1503.00 $5000.00 | ||
Tetracaine is a local anesthetic that blocks sodium channels. By inhibiting these channels, tetracaine may impair neuronal excitability in the olfactory system, which could indirectly inhibit Vmn2r79 activity. | ||||||
Hexamethonium bromide | 55-97-0 | sc-205712 sc-205712A | 10 g 25 g | $46.00 $64.00 | ||
Hexamethonium is a nicotinic acetylcholine receptor antagonist that can inhibit transmission in autonomic ganglia. By disrupting cholinergic signaling, it could have an indirect inhibitory effect on Vmn2r79's function within the olfactory system. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine is known to block olfactory receptors and has been found to inhibit certain signaling pathways. By blocking these receptors, chloroquine could inhibit the signaling cascade that involves Vmn2r79. | ||||||
Ruthenium red | 11103-72-3 | sc-202328 sc-202328A | 500 mg 1 g | $188.00 $250.00 | 13 | |
Ruthenium Red is a polycationic dye known to block calcium channels. By inhibiting these channels, it could affect the olfactory signal transduction in which Vmn2r79 is involved, leading to its inhibition. | ||||||
Lidocaine | 137-58-6 | sc-204056 sc-204056A | 50 mg 1 g | $51.00 $131.00 | ||
Lidocaine is a sodium channel blocker that can inhibit neuronal excitability. Inhibition of these channels within the olfactory pathways could reduce the activity of Vmn2r79 by decreasing the excitability of neurons it is expressed in. | ||||||